Roth Capital Predicts Bio-Path’s Q2 Earnings (NASDAQ:BPTH)
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Free Report) – Roth Capital cut their Q2 2025 earnings per share estimates for Bio-Path in a research note issued to investors on Tuesday, June 3rd. Roth Capital analyst J. Aschoff now anticipates that the company will post earnings per share of ($0.40) for the quarter, down from their prior […]
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Free Report) – Roth Capital cut their Q2 2025 earnings per share estimates for Bio-Path in a research note issued to investors on Tuesday, June 3rd. Roth Capital analyst J. Aschoff now anticipates that the company will post earnings per share of ($0.40) for the quarter, down from their prior […]
